Literature DB >> 12521400

Chronic tolerance to nicotine in humans and its relationship to tobacco dependence.

Kenneth A Perkins1.   

Abstract

Chronic tolerance to any drug of abuse traditionally has been thought critical to understanding drug dependence. This paper reviews research on chronic pharmacodynamic tolerance to nicotine in humans. An overview of tolerance and a discussion of methodological issues are first presented, followed by examination of cross-sectional comparisons of tolerance between groups differing in smoking history, as well as the few prospective studies of change in tolerance after quitting smoking. The relationship of nicotine tolerance to tobacco dependence is then evaluated. While somewhat modest in size, the literature on chronic tolerance to nicotine in humans is reasonably consistent in showing clear evidence of tolerance to subjective mood effects but little or no tolerance to cardiovascular, performance or other nicotine effects, within the limitations inherent in most human research on tolerance. However, this research also indicates that chronic tolerance to nicotine is not closely associated with tobacco dependence: non-dependent and dependent smokers are equally tolerant; tolerance declines very little even years after quitting; and tolerance before quitting may have no relationship to clinical outcome of a cessation attempt. Recent research from the alcohol and substance abuse fields is consistent with the notion that tolerance has little clinical utility in determining dependence. These results question the relevance of nicotine tolerance to dependence and suggest that research into mechanisms of tolerance, while important for understanding biological adaptation, may not elucidate factors responsible for nicotine dependence. Future research should focus on whether dependence may be related to tolerance or to other, as yet unexamined, effects of nicotine, including conditioned tolerance effects, and on the possibility that tolerance may influence the early onset of dependence in teens even if apparently unrelated to maintenance of dependence in adult smokers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12521400     DOI: 10.1080/1462220021000018425

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  26 in total

Review 1.  The feasibility of smoking reduction: an update.

Authors:  John R Hughes; Matthew J Carpenter
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

2.  How does a failed quit attempt among regular smokers affect their cigarette consumption? Findings from the International Tobacco Control Four-Country Survey (ITC-4).

Authors:  Hua-Hie Yong; Ron Borland; Andrew Hyland; Mohammad Siahpush
Journal:  Nicotine Tob Res       Date:  2008-05       Impact factor: 4.244

3.  Early course of nicotine dependence in adolescent smokers.

Authors:  Chyke A Doubeni; George Reed; Joseph R Difranza
Journal:  Pediatrics       Date:  2010-05-03       Impact factor: 7.124

Review 4.  Adolescent brain maturation and smoking: what we know and where we're headed.

Authors:  David M Lydon; Stephen J Wilson; Amanda Child; Charles F Geier
Journal:  Neurosci Biobehav Rev       Date:  2014-07-12       Impact factor: 8.989

5.  Positive reactions to tobacco predict relapse after cessation.

Authors:  David R Strong; Adam M Leventhal; Daniel P Evatt; Suzanne Haber; Benjamin D Greenberg; David Abrams; Raymond Niaura
Journal:  J Abnorm Psychol       Date:  2011-05-16

6.  Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.

Authors:  Sarah E McCallum; Allan C Collins; Richard Paylor; Michael J Marks
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

7.  Effects of chronic nicotine, nicotine withdrawal and subsequent nicotine challenges on behavioural inhibition in rats.

Authors:  K Z Kolokotroni; R J Rodgers; A A Harrison
Journal:  Psychopharmacology (Berl)       Date:  2011-11-29       Impact factor: 4.530

Review 8.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

9.  Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM).

Authors:  Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Caryn Lerman; Neal Benowitz; Michael C Fiore; Timothy B Baker
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

10.  Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.

Authors:  Kenneth A Perkins; Caryn Lerman; Sarah Coddington; Christopher Jetton; Joshua L Karelitz; Annette Wilson; J Richard Jennings; Robert Ferrell; Andrew W Bergen; Neal L Benowitz
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.